ENTX (STOCKS)
Entera Bio Ltd. Ordinary Shares
$2.870000
+0.070000 (+2.50%)
Prev close: $2.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Miranda J. Toledano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $471.69M
- Employees
- 21
- P/E (TTM)
- -8.16
- P/B (TTM)
- 18.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Cost Of Revenue | $0.00 |
| Gross Profit | $0.00 |
| Nonoperating Income/Loss | -$2.63M |
| Operating Expenses | $14.40M |
| Selling, General, and Administrative Expenses | $428.00K |
| Research and Development | $8.81M |
| Other Operating Expenses | $5.16M |
| Operating Income/Loss | -$14.40M |
| Income/Loss From Continuing Operations After Tax | -$17.03M |
| Income/Loss From Continuing Operations Before Tax | -$25.50M |
| Net Income/Loss | -$17.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.35 |
| Diluted Earnings Per Share | $0.35 |
| Basic Average Shares | 145,659,021 |
| Diluted Average Shares | 145,659,021 |
| Assets | $19.48M |
| Current Assets | $18.90M |
| Prepaid Expenses | $216.00K |
| Other Current Assets | $18.68M |
| Noncurrent Assets | $584.00K |
| Fixed Assets | $121.00K |
| Other Non-current Assets | $463.00K |
| Liabilities | $12.21M |
| Current Liabilities | $2.10M |
| Accounts Payable | $575.00K |
| Other Current Liabilities | $1.53M |
| Noncurrent Liabilities | $10.11M |
| Equity | $7.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.27M |
| Liabilities And Equity | $19.48M |
| Net Cash Flow From Operating Activities | -$10.89M |
| Net Cash Flow From Operating Activities, Continuing | -$10.89M |
| Net Cash Flow From Investing Activities | -$73.00K |
| Net Cash Flow From Investing Activities, Continuing | -$73.00K |
| Net Cash Flow From Financing Activities | $10.51M |
| Net Cash Flow From Financing Activities, Continuing | $10.51M |
| Exchange Gains/Losses | -$15.00K |
| Net Cash Flow | -$464.00K |
| Net Cash Flow, Continuing | -$449.00K |
| Comprehensive Income/Loss | -$17.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.03M |
| Other Comprehensive Income/Loss | $0.00 |